HRP20030220B1 - Bicyclic heteroaromatic compounds - Google Patents

Bicyclic heteroaromatic compounds

Info

Publication number
HRP20030220B1
HRP20030220B1 HR20030220A HRP20030220A HRP20030220B1 HR P20030220 B1 HRP20030220 B1 HR P20030220B1 HR 20030220 A HR20030220 A HR 20030220A HR P20030220 A HRP20030220 A HR P20030220A HR P20030220 B1 HRP20030220 B1 HR P20030220B1
Authority
HR
Croatia
Prior art keywords
bicyclic heteroaromatic
heteroaromatic compounds
thieno
methylthio
carboxamide
Prior art date
Application number
HR20030220A
Other languages
English (en)
Croatian (hr)
Inventor
Marius Timmers Cornelis
Frederik Johan Karstens Willem
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of HRP20030220A2 publication Critical patent/HRP20030220A2/hr
Publication of HRP20030220B1 publication Critical patent/HRP20030220B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20030220A 2000-09-22 2003-03-21 Bicyclic heteroaromatic compounds HRP20030220B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00203287 2000-09-22
PCT/EP2001/010743 WO2002024703A1 (en) 2000-09-22 2001-09-17 Bicyclic heteroaromatic compounds

Publications (2)

Publication Number Publication Date
HRP20030220A2 HRP20030220A2 (en) 2003-06-30
HRP20030220B1 true HRP20030220B1 (en) 2011-10-31

Family

ID=8172046

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030220A HRP20030220B1 (en) 2000-09-22 2003-03-21 Bicyclic heteroaromatic compounds

Country Status (32)

Country Link
US (2) US7229990B2 (is)
EP (2) EP1322651B1 (is)
JP (1) JP4977940B2 (is)
KR (1) KR100860040B1 (is)
CN (1) CN1247594C (is)
AR (1) AR030784A1 (is)
AT (1) ATE384726T1 (is)
AU (2) AU2002213929B2 (is)
BR (1) BR0113987A (is)
CA (1) CA2422054C (is)
CY (1) CY1107308T1 (is)
CZ (1) CZ297136B6 (is)
DE (1) DE60132607T2 (is)
DK (1) DK1322651T3 (is)
EC (1) ECSP034523A (is)
ES (1) ES2299524T3 (is)
HK (1) HK1054942A1 (is)
HR (1) HRP20030220B1 (is)
HU (1) HU229422B1 (is)
IL (2) IL154624A0 (is)
IS (1) IS2531B (is)
MX (1) MXPA03002478A (is)
NO (1) NO328683B1 (is)
NZ (1) NZ524444A (is)
PE (1) PE20020537A1 (is)
PL (1) PL207755B1 (is)
PT (1) PT1322651E (is)
RU (1) RU2271360C2 (is)
SK (1) SK287554B6 (is)
TW (1) TWI290143B (is)
WO (1) WO2002024703A1 (is)
ZA (1) ZA200301588B (is)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2422054C (en) * 2000-09-22 2011-01-11 Akzo Nobel Nv Bicyclic heteroaromatic compounds
TW200407127A (en) 2002-08-21 2004-05-16 Astrazeneca Ab Chemical compounds
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
US7737155B2 (en) * 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
WO2006124490A2 (en) * 2005-05-17 2006-11-23 Schering Corporation Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
JP2009537551A (ja) * 2006-05-17 2009-10-29 アメリカ合衆国 ホルモン受容体を調節するためのピリミジン低分子量リガンド
EP2280969A1 (en) 2008-04-29 2011-02-09 F. Hoffmann-La Roche AG Pyrimidinyl pyridone inhibitors of jnk.
CA2741030A1 (en) 2008-10-20 2010-04-29 Marvin C. Gershengorn Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
CA2789818A1 (en) 2010-04-08 2011-10-13 The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services Inverse agonists and neutral antagonists for the tsh receptor
EP3392252B1 (en) 2011-08-23 2023-10-04 Libertas Bio, Inc. Pyrimido- pyridazinone compounds and use thereof
CN113680386B (zh) * 2021-08-23 2023-08-11 深圳湾实验室坪山生物医药研发转化中心 氮杂环卡宾-方酰胺双功能催化剂及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995034563A1 (en) * 1994-06-16 1995-12-21 Pfizer Inc. Pyrazolo and pyrrolopyridines
WO2000061586A1 (en) * 1999-04-08 2000-10-19 Akzo Nobel N.V. Bicyclic heteroaromatic compounds useful as lh agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0920319A4 (en) * 1996-05-20 2002-05-02 Merck & Co Inc GONADOLIBERIN ANTAGONISTS
CA2422054C (en) * 2000-09-22 2011-01-11 Akzo Nobel Nv Bicyclic heteroaromatic compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995034563A1 (en) * 1994-06-16 1995-12-21 Pfizer Inc. Pyrazolo and pyrrolopyridines
WO2000061586A1 (en) * 1999-04-08 2000-10-19 Akzo Nobel N.V. Bicyclic heteroaromatic compounds useful as lh agonists

Also Published As

Publication number Publication date
AU2002213929B2 (en) 2006-04-13
IL154624A0 (en) 2003-09-17
SK3312003A3 (en) 2003-08-05
PL360675A1 (en) 2004-09-20
RU2271360C2 (ru) 2006-03-10
EP1886999A2 (en) 2008-02-13
HU229422B1 (hu) 2013-12-30
KR20030040483A (ko) 2003-05-22
BR0113987A (pt) 2003-08-12
US20030225113A1 (en) 2003-12-04
US7618963B2 (en) 2009-11-17
PL207755B1 (pl) 2011-01-31
DK1322651T3 (da) 2008-06-02
NO328683B1 (no) 2010-04-26
HUP0302648A2 (hu) 2003-11-28
NZ524444A (en) 2004-03-26
JP4977940B2 (ja) 2012-07-18
AU1392902A (en) 2002-04-02
CA2422054C (en) 2011-01-11
US20070197527A1 (en) 2007-08-23
DE60132607D1 (de) 2008-03-13
HUP0302648A3 (en) 2004-11-29
IS6732A (is) 2003-02-28
EP1886999A8 (en) 2010-08-04
CN1462273A (zh) 2003-12-17
HRP20030220A2 (en) 2003-06-30
ATE384726T1 (de) 2008-02-15
HK1054942A1 (en) 2003-12-19
PE20020537A1 (es) 2002-06-20
US7229990B2 (en) 2007-06-12
KR100860040B1 (ko) 2008-09-25
ECSP034523A (es) 2003-04-25
EP1886999A3 (en) 2008-03-12
NO20031314L (no) 2003-03-21
ZA200301588B (en) 2004-06-22
MXPA03002478A (es) 2004-05-05
DE60132607T2 (de) 2009-01-29
WO2002024703A1 (en) 2002-03-28
CZ2003828A3 (cs) 2003-08-13
AR030784A1 (es) 2003-09-03
IL154624A (en) 2009-09-01
TWI290143B (en) 2007-11-21
PT1322651E (pt) 2008-02-28
EP1322651A1 (en) 2003-07-02
CA2422054A1 (en) 2002-03-28
NO20031314D0 (no) 2003-03-21
EP1322651B1 (en) 2008-01-23
CY1107308T1 (el) 2012-11-21
JP2004509896A (ja) 2004-04-02
CZ297136B6 (cs) 2006-09-13
IS2531B (is) 2009-07-15
ES2299524T3 (es) 2008-06-01
CN1247594C (zh) 2006-03-29
SK287554B6 (sk) 2011-01-04

Similar Documents

Publication Publication Date Title
HRP20010573B1 (en) Tricyclic inhibitors of poly(adp-ribose) polymerases
PT1289992E (pt) Nova forma cristalina de um composto de triazolo (4,5-d) pirimidina
CA2416867A1 (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
SI1379511T1 (en) DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II
HRP20030220B1 (en) Bicyclic heteroaromatic compounds
MA26824A1 (fr) 5-(2-substitué-5-hétérocyclylsulfonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidine-7-ones servant d'inhibiteurs de phosphodiestérase.
HK1118534A1 (en) Thieno-pyrimidine compounds having fungicidal activity
HRP20010117B1 (en) Novel salt form of pantoprazole
DZ3266A1 (fr) Pyrido[2,3-d]pyrimidine-2,7-diamine inhibiteurs de kinase
MXPA03009317A (es) Derivados de dihidro-benzo(b)[1,4]diazepin-2-ona como antagonistas i del receptor metabotropico de glutamaco (mglur2).
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
HRP20010238B1 (en) 2-methyl-thieno-benzodiazepine formulation
ATE248822T1 (de) Partikel mit kontrollierter freisetzungsrate
HK1061026A1 (en) 3,7-Diazabicyclo 3.3.1Ü formulations as antiarhythmic compounds
DE50101861D1 (de) Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung
AU5539899A (en) Novel triazolo(4,5-(d))pyrimidine compounds
TR199901017A2 (xx) B�cek ilac� terkibi.
MXPA03004498A (es) Uso de pirazolo (4,3-d)pirimidinas.
GB2418915B (en) Fragrance compositions comprising benzo[4,5]thieno[3,2-B]pyran-2-one
AU9069201A (en) Interheteroaryl 7-oxabicyclic (2.2.1)heptane oxazoles as prostaglandin F<sub>2alpha</sub> antagonists
PL366629A1 (en) 3,7-diazabicyclo [3.3.1] formulations as anti-arrythmic compounds
PL356668A1 (en) Novel substituted pyrazolo[4,3-e
SI0915087T1 (en) Sulfonamide substituted fused five-membered ring compounds, their use as medicaments as well as pharmaceutical compositions containing them
IL144126A0 (en) A method of altering the specificity of cyclooxygenase-inhibiting compounds

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PPPP Transfer of rights

Owner name: N.V. ORGANON, NL

B1PR Patent granted
PPPP Transfer of rights

Owner name: MSD OSS B.V., NL

PPPP Transfer of rights

Owner name: ORGANON BIOSCIENCES NEDERLAND B.V., NL

ODRP Renewal fee for the maintenance of a patent

Payment date: 20140826

Year of fee payment: 14

PBON Lapse due to non-payment of renewal fee

Effective date: 20150917